Advances in Analytics for Bioprocessing

Richard Moseley, Chief Technologist at Microsaic talks to Biopharma International about process analytical technology (PAT) for monitoring and controlling biopharma production processes.

When FDA’s process analytical technology (PAT) initiative was first unveiled, the aim was to have the industry move away from a mindset of “testing quality” at the end of production to instead develop methods that monitor, assess, predict, and control quality from the start of the manufacturing process. PAT tools have facilitated ongoing monitoring and adjustment of bioprocesses to ensure that biologic drug products are produced with high quality, meeting the required specifications all the time.

 

Founded in 2001, Microsaic Systems plc (LON:MSYS) is a high technology company which develops point-of-need mass spectrometers, designed to improve the efficiency of chemical and biological workflows.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Microsaic Systems plc

    More articles like this

    CEO Q&A with Glenn Tracey at Microsaic Systems (LON:MSYS)

    Microsaic Systems’ Glenn Tracey discusses the highlights from their final results, what the 12 OEM & distribution agreements mean to the business operationally, the benefits of the MiD ProteinID products and how the new financial year has started in this exclusive interview with DirectorsTalk.

    Microsaic Systems Delivering a good year of growth

    Microsaic Systems plc (LON:MSYS) CEO Glenn Tracey joins DirectorsTalk to discuss full year results. Glenn talks us through the highlights, with 12 OEM and distribution agreements in place what this means for the business, the benefits the

    Microsaic Systems to further strengthen capabilities in 2020

    Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, today announced its audited financial results for the year ended 31 December 2019. The Company’s Annual Report is included at the end

    Microsaic Systems appoint WH Ireland as Joint Broker

    Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, has today announced the appointment of WH Ireland Limited as Joint Broker with immediate effect, alongside N+1Singer as Nominated Adviser and Joint Broker.

    Microsaic Systems partner with Axcend Corp

    Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, today announced that it has signed a global integration and joint sales and marketing heads of terms with Axcend Corp to integrate the

    Microsaic Systems Growing pipeline of opportunities

    Microsaic Systems (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, has today confirmed that revenues for the year ending 31 December 2019 have significantly exceeded 2018, and increasing momentum is being achieved in

    Microsaic Systems plc

    Microsaic Systems plc Deepens collaboration with Chinese partner

    Microsaic Systems plc (LON: MSYS), the developer of point of need mass spectrometry (“MS”) instruments, announces that its Chinese partner, Unimicro Technologies Inc. (“Unimicro”), has completed further integrations of Microsaic’s technology with Unimicro’s separation technology. Glenn

    Microsaic Systems plc

    Microsaic Systems plc AGM and Posting of Annual Report

    Microsaic Systems plc (LON: MSYS), the developer of point of need mass spectrometry instruments, has today announced that its Annual General Meeting will be held at 11.00 a.m. on 14 May 2019 at the offices of N+1